SHaRe Registry Identifies MACE Predictors in Mild HCM
A study of 2,500 patients in the SHaRe Registry found that one in five individuals with mild hypertrophic cardiomyopathy experienced major adverse cardiovascular events over seven years. Key risk predictors included older age, symptom progression, and specific structural heart measurements.
About one in five patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events (MACE) over seven years of follow-up, according to SHaRe Registry research published July 8 in JACC . Older age, symptom progression and increases in left atrial (LA) diameter, left ventricular (LV) hypertrophy and LV outflow tract (LVOT) gradient were among the strongest predictors of risk.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in